Castrol India and Gland Pharma Removal The National Stock Exchange (NSE) has declared that shares of Castrol India and Gland Pharma will no longer be a part of the Futures & Options (F&O) segment from January 31, 2025. This announcement comes after an earlier decision to include six new companies in the F&O segment starting …